Literature DB >> 25219736

Photo-induced erythema multiforme associated with vandetanib administration.

Dolores Caro-Gutiérrez1, Maria Uxúa Floristán Muruzábal2, Enrique Gómez de la Fuente2, Ana Pampín Franco2, José Luis López Estebaranz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25219736     DOI： 10.1016/j.jaad.2014.05.003

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Development of Photoonycholysis with Vandetanib Therapy.

Authors:  Miruna Negulescu; Slimane Zerdoud; Serge Boulinguez; Emilie Tournier; Jean-Pierre Delord; Robert Baran; Vincent Sibaud
Journal:  Skin Appendage Disord       Date:  2016-11-03

Review 2.  Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).

Authors:  Emily L Coleman; Brianna Olamiju; Jonathan S Leventhal
Journal:  Oncol Rep       Date:  2020-12-24       Impact factor: 3.906

Review 3.  Management of Dermatologic Toxicities Associated With Targeted Therapy.

Authors:  Mario E Lacouture
Journal:  J Adv Pract Oncol       Date:  2016-04-01

Review 4.  Anticancer treatments and photosensitivity.

Authors:  V Sibaud
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06       Impact factor: 9.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.